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Mosquito repellency data on acylpiperidines derived from the U.S.
Department of Agriculture archives were modeled by using mo-
lecular descriptors calculated by CODESSA PRO software. An arti-
ficial neural network model was developed for the correlation of
these archival results and used to predict the repellent activity of
novel compounds of similar structures. A series of 34 promising
N-acylpiperidine mosquito repellent candidates (4a–4q) were syn-
thesized by reactions of acylbenzotriazoles 2a–2p with piperidines
3a–3f. Compounds (4a–4q) were screened as topically applied
mosquito repellents by measuring the duration of repellency after
application to cloth patches worn on the arms of human volun-
teers. Some compounds that were evaluated repelled mosquitoes
as much as three times longer than N,N-diethyl-m-toluamide
(DEET), the most widely used repellent throughout the world. The
newly measured durations of repellency were used to obtain a
superior correlation equation relating mosquito repellency to mo-
lecular structure.
N-acylpiperidine  quantitative structure–activity relationship 
CODESSA PRO  artificial neural network  Aedes aegypti
Mosquito-borne diseases such as malaria, arboviral enceph-alitis, dengue fever, Rift Valley fever, and yellow fever
produce significant morbidity and mortality in humans and
livestock in many parts of the world (1). Pathogens that cause
these diseases are transmitted by injection of saliva into suscep-
tible hosts by female mosquitoes needing protein from a blood
meal to develop their eggs. Repellents play a vital role in
interrupting this mosquito/human interaction by serving as a
means of personal protection by reducing bites frommosquitoes.
Although vaccines and genetically modified mosquitoes are
under development for prevention of mosquito-borne diseases,
new and improved topical repellents are needed to provide
alternatives that are safer, effective for a longer duration, and more
efficacious against mosquitoes and a wide range of arthropods.
Some repellents that are applied to the skin or clothing are
highly effective but only of limited duration because of evapo-
rative loss, dermal absorption, abrasive loss, or dissolution in
water and perspiration (2, 3). Furthermore, some compounds
cause skin irritation or a stinging sensation when they contact
eyelids or lips. Finally, several are successful at preventing bites
only when they are present on the skin or clothing in relatively
large quantities. Thus, the current research is driven by the need
to discover a new generation of repellents that overcome these
limitations and supplement or replace today’s standard repellent
(N,N-diethyl-m-toluamide, DEET).
Insects are believed to detect repellents through receptor
uptake of molecules with specific chemical characteristics (4–7).
Therefore, we have conducted extensive studies of the relation-
ship between molecular structure and the observed biological
property of repellency. Our approach is based on a rational
design similar to that used by the pharmaceutical industry for
drug development but, in this case, is specifically aimed at
products that interfere with mosquito olfaction and/or deter
biting of a host. The use of quantitative structure–activity
relationship (QSAR) approaches to repellent discovery is rela-
tively uncommon (8). In one of the most recent studies, three-
dimensional (3D)-QSAR was used successfully with CATALYST
software to develop models for repellents based on pharma-
cophores (8). We have chosen to use artificial neural network
(ANN) modeling because it is one of the most efficient QSAR
approaches. Neural networks have been applied in many diverse
scientific endeavors, including economics, engineering, physics,
chemistry, and medical science (9). A particular advantage of
ANNs is their inherent ability to incorporate nonlinear depen-
dencies between the dependent and independent variables with-
out using an explicit mathematical function.
Methodology for a general QSAR approach has been devel-
oped and coded as the CODESSA PRO software package (10).
We previously examined 31 repellents by using CODESSA PRO
(11) and here extend this research by examining available data
on N-acylpiperidines, calculating their structure–activity rela-
tionships, synthesizing novel compounds, and performing repel-
lency assays with human volunteers (12).
Results and Discussion
Correlation of Existing Mosquito Repellency Data for N-acylpiperidines
with Chemical Structures. Dataset. Early investigations on the
synthesis of insect repellents and their practical tests on skin and
cloth against mosquitoes and other biting Diptera have been well
documented (13–24). In the present work, nonlinear QSAR
modeling based on the ANN approach was performed using
available data for 200 N-acylpiperidines. The efficacy of these
compounds was determined by a ‘‘time point of failure’’ defined
as a specified number of bites (usually a low number) by female
Aedes aegypti (L.) mosquitoes through cloth treated with each
candidate piperidine and fixed on the arm of a volunteer (12).
The original data on piperidines were obtained from U.S.
Department of Agriculture (USDA) records collected and com-
piled over the past 50 years (25–27). Historically, the level of
repellency was divided into five classes, as defined by ‘‘the time
to first bite.’’ This classification system placed all repellents that
were efficacious for 21 d into class 5, the top tier. The
remaining classes were divided as class 4 for 10- to 21-d
protection, class 3 for 5- to 10-d protection, class 2 for 1- to 5-d
protection, and class 1 as ineffective (1-d protection).
Nonlinear QSAR modeling. The objective of these calculations was to
build a predictive ANN model able to classify the duration of
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repellent efficacy and use this information to predict structures
of novel repellents. The data set was divided into training (150
repellents) and validation (50 repellents) subsets. The main
model is based on the back propagation learning algorithm for
optimization of the ANN (28, 29). To obtain good generalization
of the ANN, the following factors were taken into account:
(i) To build a general model, 150 of the 200 compounds [see
supporting information (SI) Table S1 for details] were randomly
selected to form the training set.
(ii) The preferred architecture of the ANN model (by rms
error) was 8-7-1 (i.e., 8 neurons in the input layer, 7 neurons in
the hidden layer, and 1 neuron in the output) representing the
time class of the repellent.
(iii) A sensitivity analysis was done by building 1-1-1 ANN
models, and the descriptors that showed lowest error at the
output were selected. In addition, scatter plot analysis between
the descriptors and the time classes was carried out to reveal the
variability of the classes with respect to the descriptors. Finally,
a combination of eight descriptors was selected as inputs for the
ANN: total number of bonds, molecular weight, Kier and Hall
index (order 3), molecular surface area, total dipole of the
molecule, total molecular electrostatic interaction, surface area
for atom C, and surface area for atom N.
The training procedure of the ANN was stopped when the rms
error of the validation set started to increase. The final results for
the coefficient of determination and rms error for the training
set were 0.73 and 0.87, respectively. The calculated rms error of
the validation set was 1.4. As expected, the rms error of the
validation set was bigger than that of the training subset.
Utilization of the ANNModel to Design and Select New Compounds for
Synthesis. Discussion of the ANN model. Based on the results ob-
tained by the ANN model, the repellent time classes for addi-
tional compounds were predicted. The expected accuracy of
prediction of the repellency class for a new compound by using
the results on measured compounds is given by Ns/N, where Ns
is the number of the repellents predicted by the network at this
particular class and N is the total number of the repellents in a
given experimental class. Thus, the accuracies of each class are
as follows (see Fig. S1 for more information): class 1, 0.76; class
2, 0.69; class 3, 0.50; class 4, 0.25; and class 5, 0.35. If classes 4
and 5 are combined into a single class, the exact number of
compounds predicted from class 4 and class 5 combined is 39.
Therefore, the predicted accuracy for class 4 and class 5 com-
pounds is 71% (39/55). This prediction accuracy is quite high,
considering the distribution of the class values. Therefore, this
ANN model can be used with some confidence to predict novel
candidate repellents.
Selecting compounds for synthesis. Good correlation existed be-
tween the experimental and predicted values of the repellent
efficacy. Of the 34 compounds selected for synthesis, 11 of these
(see Table 1 and Table S2 for more details and refs. 20 and
30–33) were chosen from those examined previously. The re-
pellency of these 11 compounds was reassessed to (i) compare
results obtained from the biological test procedure to experi-
mental results of those conducted and reported previously (26);
(ii) conduct a rigorous assessment of the testing protocol using
new analogs and thereby to gain confidence in the utility of the
output data; and (iii) increase predictive ability and accuracy by
reexamination of the most effective repellent candidates iden-
tified as class 4 and class 5 from previous assays and then use the
protocols to further divide the repellency of these compounds
into additional subclasses.
At present, the activities of2,000 untested analogs have been
predicted. A total of 23 were selected from this set for synthesis.
Using the ANN model, we predicted these compounds to be
principally members of repellent classes 3, 4, and 5 (see Table 1
and Table S3 for details, and refs. 15, 20, and 33–38). Thus,
together with the 11 compounds previously examined (see Table
1) with activity predicted by the ANN as classes 4 and 5, we
synthesized a total of 34 compounds of general structure 4 as
shown in Fig. 1.
Synthesis of Additional N-acylpiperidines. Introduction.N-acylpiperi-
dines have generally been synthesized by reaction of acid chlo-
rides with amines (either the amine itself or pyridine was used
as a hydrochloric acid scavenger). The product amides are then
isolated by routine extraction procedures and purified by crys-
tallization, chromatography, or distillation under high vacuum.
The high reactivity of acid halides and their incompatibility
with acid-sensitive functionalities prompted efforts to find al-
ternative methods. A benzotriazolyl group is easily introduced,
activates molecules toward numerous transformations, and can
be removed easily at the end of each reaction sequence (39–44).
1-Acylbenzotriazoles are advantageous carboxylic acid deriva-
tives because they are stable and readily available in one step
from carboxylic acids even where an acid-sensitive functionality
is present (45–47). We report herein the use of this method in
the synthesis of N-acylpiperidines as candidates for mosquito
repellents.
Synthetic results and discussion. 1-Acylbenzotriazoles 2 (Fig. 1) were
produced by treatment of the corresponding carboxylic acids 1
at 25°C with thionyl chloride and benzotriazole in methylene
chloride in 1:1:3 mole ratio (48).
Reaction of 1-acylbenzotriazoles 2 with 1 eq of piperidines 3
in THF at 20°C or in toluene under reflux resulted in formation
of N-acylpiperidines 4 by our modified procedure (46). Subse-
quent evaporation of the solvent, addition of methylene chloride,
and washing with aqueous sodium carbonate solution gave
N-acylpiperidines 4a–4q in 71–100% yield (Tables S2 and S3).
Experimental (if available) and predicted classes of repellency
according to the ANN model are given in Table S1. From these
data, the 11 candidates reselected for synthesis are listed in Table
1 and Table S2. These compounds have the highest measured
activity (i.e., class 5) and also possess high activities predicted by
the ANN model.
Another 23 compounds were synthesized as repellent candi-
dates (Table 1 and Table S3). Of these, 17 (74%) were predicted
by ANN as highly active repellents falling in classes 4 and 5,
which in theory provide protection from mosquito bites for 10
d when applied to cloth worn over the skin. For controls, we also
synthesized six compounds with relatively poor (classes 1 and 2)
predicted repellency (4a–4f, Table 1, Table S3). Measurements
of the biological activity of all these compounds are described in
the section on biological testing.
NMR Spectra of N-acylpiperidines. The proton spectra of the
unsymmetrical amides 4a, 4c, 4h, 4i, 4l, 4p, 4q, 4c, 4h–k, 4n,
and 4o all revealed hindered rotation about the N–CO bond on
the NMR time scale. Detailed variable temperature NMR
spectra of 4c, 4p, and 4q gave G‡ values of 16.2  0.3
kcalmol1 for interconversion of the rotamers, corresponding to
a first-order rate constant of 30 s1 at ambient temperature.
Thus, hindered rotation is not expected to influence the biolog-
ical activity (see SI Text, Figs. S2–S5, and Table S4 for more
details).
Biological Testing. Initially, mass concentrations (12) were used at
the start of experiments, but a modification of the initial experi-
mental setting was necessary so that the current modeling scheme
would meet one of the following QSAR conditions (i) measure-
ment of the induced biological effect at a constant concentration or
(ii) measurement of the concentration that causes a constant
biological effect. The first condition is closer to the actual appli-
cation rate of repellents in the field and thus was chosen for further
study. The experimental determination of repellency was based on
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two tests per compound performed at 2.5 and 25 mol/cm2
concentrations, and average protection times (d) were derived from
the two tests (see Table 1).
The repellent 4-methyl-1-(1-oxooctyl)piperidine (4f ) (at 25
mol/cm2) failed on day 43 for the female volunteer, whereas the
male had a repellent, 2-ethyl-1-(1-oxo-10-undecylenyl)piperi-
dine (4l) that provided protection for 85 d. With both the male
and female volunteers repellency persisted for 73 d at 25
mol/cm2 with 4-methyl-1-(1-oxo-10-undecylenyl)piperidine
(4n). Repellent 4l was the most potent toxicant as measured by
LD50 of the repellents examined by Pridgeon et al. (49). For
comparison, and highly illustrative of the efficacy of these
candidate repellents, the failure point (protection time) for 25
mol/cm2 DEET on cloth averaged 17.5 d for this screening
assay. At the low dose of 2.5 mol/cm2, repellent 4k, 1-(1-oxo-
10-undecylenyl)piperidine, averaged 13.5-d protection com-
pared with only 2.5-d protection for the 2.5 mol/cm2 DEET
standard.
Statistical examination of the average protection times (PT)
revealed several important characteristics.
(i) The distribution of the data at 2.5 mol/cm2 is close to
normal (Gaussian), whereas the one at 25 mol/cm2 deviates
slightly (see Fig. 2).
2) Perhaps because most of the compounds measured were
highly active, the experimental PT values at the lower concen-
Table 1. Predicted ANN class, averaged experimental protection time (PT) from tests 1 and 2, standard deviation of the data,
and converted class
Compound
Predicted
ANN class*
PT, d, at 25 mol/cm2
Conv.
class
PT, d, at 2.5 mol/cm2
Conv.
classID no. R R Test 1 Test 2 Average Test 1 Test 2 Average
DEET 14 21 17.5 4 2 3 2.5 2
4a Me 2-Me 4.82 5 1 3 2 2 1 3 2 2
4b Et H 4.56 5 7 3 5 2 1 7 4 2
4c Et 2-Et 4.10 4 3 7 5 2 3 3 3 2
4d n-C6H13 2-Me 3.14 3 17 17 17 4 3 7 5 2
4e n-C6H13 3-Me 3.11 3 14 17 15.5 4 7 8 7.5 3
4f n-C7H15 4-Me 2.69 3 43 53 48 5 9 7 8 3
4g n-C7H15 4-Bn 1.82 2 9 17 13 4 7 7 7 3
4h n-C8H17 2-Et 3.01 3 23 63 43 5 10 9 9.5 3
4i n-C9H19 2-Me 2.85 3 21 78 49.5 5 9 7 8 3
4j n-C9H19 4-Me 2.78 3 23 59 41 5 9 14 11.5 4
4k† CH2CH(CH2)8 H 3.87 4 37 63 50 5 10 17 13.5 4
4l CH2CH(CH2)8 2-Et 1.56 2 21 85 53 5 9 9 9 3
4m CH2CH(CH2)8 4-Bn 1.11 1 7 10 8.5 3 7 9 8 3
4n CH2CH(CH2)8 4-Me 2.26 2 73 73 73 5 0 21 10.5 4
4o n-C10H21 H 2.12 2 23 56 39.5 5 9 17 13 4
4p n-C11H23 2-Me 3.63 4 7 22 14.5 4 3 7 5 2
4q n-C11H23 3-Me 1.64 2 10 29 19.5 4 3 8 5.5 3
4a† 1-c-C6H9 H 4.87 5 17 17 17 4 3 7 5 2
4b† c-C6H11 H 5.21 5 14 14 14 4 7 9 8 3
4c† c-C6H11 3-Me 5.01 5 17 17 17 4 3 9 6 3
4d† c-C6H11 4-Me 5.02 5 28 21 24.5 5 7 10 8.5 3
4e† c-C5H9(CH2)2 H 4.33 4 28 42 35 5 9 9 9 3
4f† 1-Me-c-C6H10 3-Me 3.98 4 10 14 12 4 7 7 7 3
4g 4-Me-c-C6H10 2-Me 4.98 5 28 38 33 5 8 9 8.5 3
4h† c-C6H11 2-Et 5.23 5 21 22 21.5 5 7 7 7 3
4i† c-C6H11CH2 2-Me 4.55 5 24 35 29.5 5 7 8 7.5 3
4j† c-C6H11(CH2)2 2-Me 3.56 4 29 66 47.5 5 10 10 10 3
4k† c-C6H11(CH2)2 3-Me 3.62 4 14 56 35 5 7 11 9 3
4l c-C6H11(CH2)2 4-Me 4.03 4 28 63 45.5 5 7 9 8 3
4m c-C6H11(CH2)3 4-Me 3.66 4 10 56 33 5 3 3 3 2
4n c-C5H9(CH2)2 2-Et 4.74 5 23 58 40.5 5 7 10 8.5 3
4o c-C6H11(CH2)2 2-Et 4.34 4 21 63 42 5 0 21 10.5 4
4p c-C6H11CH2 4-Bn 3.56 4 3 3 3 2 0 3 1.5 2
4q c-C6H11(CH2)2 4-Bn 2.98 3 7 17 12 4 1 1 1 1
Bn, benzyl.
*ANN predicted class, three significant figures on the left, rounded on the right.
†Repellents that had previously been evaluated for repellent classes; all others are candidate repellents synthesized for this study.
Fig. 1. Synthetic scheme for the preparation of N-acylpiperidines 4. Bt,
benzotriazolyl.
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tration of 2.5 mol/cm2 are more precise than those at 25
mol/cm2. Hence, the QSAR modeling results at the lower
concentration are expected to be more reliable.
Comparison of the Present Bioassay Values with the Archival Data.
The dataset of 34 N-acylpiperidines with averaged PT trans-
formed into classes was used to estimate the predictive power of
ANN. No significant correlation was found between the exper-
imental PT values and those predicted by ANN at either 25 or
2.5 mol/cm2 (columns 5 vs. 10 and 5 vs. 15 produced R2 0.007
and R2 0.06, respectively). The possible mismatch between the
ANN-predicted classes (based on archival data) and those
measured in the present work could be due to the significant
difference in the experimental settings: mass instead of molar
concentrations used, fewer mosquitoes tested (500 instead of
2,000–4,000), different cage size, and use of a new PT definition
(see Methods).
We conclude that the use of classes as such is not appropriate
and does not provide sufficient levels to clearly discriminate the
repellency effectiveness of these compounds. We now use the
average days of protection (duration) as a more precise basis for
QSAR modeling.
New QSAR Modeling. By using the Best Multilinear Regression
(BMLR) algorithm integrated into CODESSA PRO
[CODESSA PRO Software, University of Florida (2002), ww-
w.codessa-pro.com], QSAR models with up to seven descriptors
[the maximum allowed by ‘‘5-to-1’’ rule of thumb (50)] were
generated for both concentrations of the candidate repellents.
As can be seen from Fig. 3, the models with four and more
descriptors are characterized by very close statistical parameters.
Following the ‘‘Occam’s Razor’’ rule of simplicity, QSAR mod-
els with four descriptors were preferred and considered further
(Table 2 and Fig. 4), thus making the comparison of the two
models easier. Using four descriptors, we obtain superior R2
values of 0.729 and 0.689 for the 25 mol/cm2 and 2.5 mol/cm2
concentration data sets, respectively.
As can be seen from Table 2, the statistical parameters
obtained in both cases are close, whereas the descriptors that
appear in the two models are quite different. The reasons for
such behavior may be as follows:
(i) Data distribution: a subtle distinction in the data distribu-
tion could lead to selection of a different descriptor set that fits
the experimental data best.
(ii) High intercorrelation: at each consecutive step the BLMR
algorithm selects only one of a pair or a set of highly intercor-
related descriptors, which is considered further. Thus, depending
on the data set, different but physically similar and highly
intercorrelated descriptors (Table S5) may appear in the differ-
ent models.
The descriptors introduced into the two models (Table 2) may
be classified as (i) electrostatic interaction-related descriptors:
RNCG relative negative charge (QMNEG/QTMINUS), mini-
mum e–n attraction for bond C–O, WPSA-2 weighted PPSA
(PPSA2*TMSA/1000), maximum 1-electron reactivity index for
atom C, and maximum e–e repulsion for bond C–C; and (ii)
steric interactions-related descriptors: YZ shadow/YZ rectangle,
molecular volume/XYZ box, principal moment of inertia Z.
The mechanism of repellent action is known to be receptor-
based, possibly involving the GPRor7 receptor (until recently, it
was designated as AgOR7) on mosquito antennae as a target for
the bioactive molecules (51). The first class of descriptors could
be related to orientation effects and to the possibility of ligand–
receptor noncovalent bonds. Most of the electrostatic descrip-
tors depict the distribution of negative charge within the mole-
cule and are probably connected to the heteroatoms present,
such as oxygen and nitrogen. Especially the ‘‘Minimum e–n
attraction for bond C–O’’ descriptor shows how important the
presence of a carbonyl group is for the repellent effect and
indicates that the stronger the –CO bond the longer the
protection time.
The second set of descriptors encoding the mass distribution
and the size of the molecules probably depict the steric inter-
actions that are responsible for the surface recognition between
the ligand and receptor. The structures identified on the basis of
our models as highly active at both concentrations (4k, 4j, 4i, 4o,
4n, 4o, 4f, 4l, 4j, and 4h) (Table 1 and Table S6) probably
include all the structural features essential for repellency.
Conclusion
This report documents significant findings in the area of repel-
lent research through the application of a combination of
techniques and methods from the disciplines of medical ento-
mology and synthetic and theoretical chemistry. Models were
constructed by using a subset of 30,000 chemicals accumulated
in the USDA archives over the last 60 years. The repellency
assays originally used to study these archived chemicals were the
Fig. 3. Plot of R2 vs. number of descriptors used.
Fig. 4. Predicted vs. observed protection time values at concentrations 25
and 2.5 mol/cm2.
Fig. 2. Histograms and probability density functions of the averaged pro-
tection time (PT) at 25 mol/cm2 (a) and 2.5 mol/cm2 (b).
7362  www.pnas.orgcgidoi10.1073pnas.0800571105 Katritzky et al.
same as those that led to the discovery of DEET in 1953, the
most widely used repellent in the United States. The appeal of
DEET as the ‘‘gold standard’’ is based on its excellent human-use
safety record, its ability to protect humans from bites of a wide
range of hematophagous arthropods, and its duration of pro-
tection on the skin—the measure of merit for the original
repellency assays and for those used in the current study. While
some newer commercial repellents are nearly as efficacious as
DEET-based repellents with respect to their protection from
insect bites, to the best of our knowledge, none protect users for
significantly longer than equivalent stoichiometric or gravimetric
amounts of DEET.
In this study, we performed a successful closing of the
‘‘QSAR–synthesis–bioassay’’ cycle. Using the original data, lin-
ear and nonlinear QSAR approaches were applied consecutively
to two series of 200 and 34 compounds, respectively. On the basis
of this model, we identified 23 compounds for synthesis and
study that we expected to be as efficacious as DEET. Modifi-
cation of the original repellency assays, including application of
chemicals in stoichiometrically equivalent amounts and convert-
ing from a class system to recording of actual days of protection,
confirmed that most of these novel acylpiperidines were equiv-
alent to or better than DEET in duration of protection. Aston-
ishingly, a number of these protected3 times as long as DEET.
Finally, the new repellency data were incorporated into struc-
ture–activity models and produced exceptional correlation co-
efficients. Modifications and retraining of the model will be
expected as we assess the chemical-structural impact of new
classes of compounds on mosquito repellent efficacy.
Methods
Synthesis. See SI Text.
Biological Testing. Laboratory-reared Aedes aegypti mosquitoes (Orlando
strain, 1952) were obtained from the USDA-Agricultural Research Service
Gainesville colony. Adults were provided with sugar and water and main-
tained nulliparous in laboratory cages at an ambient temperature of 28 1°C
and relative humidity of 35–60%. Repellency assays were conducted in 45
cm 	 37.5 cm 	 35 cm (59,000 cm3) cages containing 500  50 mosquitoes
(5–10 d old). Female mosquitoes were preselected from those that did not
display host-seeking behavior and from males by capture in a trap after
anemotaxis toward odors from a human hand in a draw box (52) and then
were transferred to a test cage for acclimatization for 15–20 min before
bioassays.
Two concentrations of each candidate repellent were prepared in a 2-dram
vial with acetone (1 ml) as the solvent. An appropriate amount of each
piperidine was added to the vials to produce a deposition of 25 mol and 2.5
mol of each piperidine, respectively, per cm2 on a 50 cm2-section of muslin
cloth that was inserted into the vial. Each cloth and solution were kept sealed
in vials and stored in a freezer at 4°C until used on ‘‘day 0.’’ On day 0, each
cloth was removed from its vial and mounted on two sections of 5 cm	 2.5 cm
card stock. Masking tape was applied to the card stock edges and the assembly
was hung from a rack and allowed to dry for at least 1 h.
Two volunteers (one male and one female) participated in this study. The
protocol was approved as project 636-2005 by the University of Florida Human
Use Institutional Review Board-01. Informed consent was obtained for sub-
jects before participation in this study. Bioassays were conducted by covering
the volunteer’s hand with a soft-embossed long cuff poly glove (Atlantis
Products) and then covering the same hand with a powder-free latex glove
(Diamond Grip, Microflex). A stocking (Leggs everyday knee highs) was then
pulled over the hand and arm to cover the skin surface of the arm. A polyvinyl
plastic sleeve, with a Velcro seam to seal the edges around the arm, and with
a 3	 8 cm opening (i.e., window) cut into the plastic approximately half way
between the wrist and elbow end of the sleeve, was fastened around the arm.
Each cloth patch assembly was affixed, one at a time, over the open window
with masking tape to hold it in place on the sleeve. This allowed volatile
kairomones to pass from the skin surface through the window opening and
attract mosquitoes which might, if the treatment was not sufficiently repel-
lent, bite through the cloth in the open window. All 2.5 mol/cm2 samples
were assayed before the 25 mol/cm2-treated patches; however, the order
within each concentration group was random, differing not only for the
individual volunteers but also day-to-day for a single individual.
The arm and affixed cloth patch were inserted into the cage of mosquitoes
and held stationary for 1 min to determine whether the cloth patch was
repellent. The number of feeding mosquitoes was counted before removal of
the arm with a quick, brisk shaking movement. This procedure was repeated
daily until the failure threshold was reached. Feeding mosquitoes that re-
mained on the window were considered to be biting. A maximum of 10
different repellents were assayed with the same group of preselected mos-
quitoes. Each additional set of 10 candidate repellents was run in a separate
cage of 500 mosquitoes. This procedure minimizes the fatigue and attenu-
ated response of mosquitoes subjected to repeated exposures to repellents, it
and avoids depletion of sufficient numbers of fresh mosquitoes to conduct
bioassays with all compounds at both concentrations from day 0 onward.
The failure threshold for repellency for these experiments was established
as 1% biting (5 bites) and confirmed by achievement of two consecutive days
of 5 or more bites. The failure point was ultimately recorded as the first day,
rather than the second day, that 5 bites were achieved through a repellent-
treated cloth.
ACKNOWLEDGMENTS. WethankDrs.GrahamWhite,DavidCarlson,andRobert
Vander Meer for support and helpful discussions with this endeavor and Natasha
Elejalde and Nathan Newlon for laboratory technical support with the biological
testing of candidate repellents. This study was partly supported by the Deployed
War-Fighter Protection Research Program, funded by the U.S. Department of
Defense through the Armed Forces Pest Management Board.
Table 2. Best four descriptors models and their statistical parameters
Conc.,
mol/cm2
No. of
descriptors B S t IC Name of descriptor
25† 0 188.8 84.08 2.246 Intercept
1 2686 461.3 5.823 0.09647 Maximum 1-electron reactivity index for atom C
2 2616 488.2 5.359 0.7253 Principal moment of inertia C
3 2.040 0.6920 2.948 0.3632 Maximum e–e repulsion for bond C–C
4 0.02195 0.009215 2.382 0.7759 WPSA-2 weighted PPSA (PPSA2*TMSA/1000)
2.5‡ 0 726.1 329.3 2.205 Intercept
1 68.13 9.393 7.254 0.5248 YZ shadow/YZ rectangle
2 58.50 13.22 4.426 0.7120 Molecular volume/XYZ box
3 71.37 16.41 4.350 0.5696 RNCG relative negative charge (QMNEG/QTMINUS)
4 1.870 0.8053 2.321 0.2822 Minimum e–n attraction for bond C–O
B, regression coefficient; S, regression coefficient error; t, Student criterion; IC, partial intercorrelation; PPSA, partial positively charged molecular surface area;
WPSA, weighted PPSA; RNCG relative negative charge, ratio between the maximum atomic negative charge and sum of the negative atomic charges in the
molecule.
†N  4; n  34; R2  0.729; RcvOO
2  0.638; RcvMO
2  0.628; F  19.50; s  9.769.
‡N  4; n  34; R2  0.689; RcvOO
2  0.608; RcvMO
2  0.582; F  16.05; s  1.815.
Katritzky et al. PNAS  May 27, 2008  vol. 105  no. 21  7363
CH
EM
IS
TR
Y
1. Eldridge BF, Edman JD (2004) Introduction to medical entomology. Medical Entomol-
ogy: A Textbook on Public Health and Veterinary Problems Caused by Arthropods, eds
Eldridge BF, Edman JD (Kluwer, London), pp 1–12.
2. Rueda LM, Rutledge LC, Gupta RK (1998) Effect of skin abrasions on the efficacy of the
repellent deet against Aedes aegypti. J Am Mosq Control Assoc 14:178–182.
3. Dethier VG (1947)Chemical InsectAttractants andRepellents (Blakiston, Philadelphia).
4. Bowen MF, Davis EE, Romo J, Haggart D (1994) Lactic acid sensitive receptors in the
autogenous mosquito Aedes atropalpus. J Insect Physiol 40:611–615.
5. Klun JA, Schmidt WF, Debboun M (2001) Stereochemical effects in an insect repellent.
J Med Entomol 38:809–812.
6. Nolen JA, Bedoukian RH, Maloney RE, Kline DL (2002) Method, apparatus and com-
positions for inhibiting the human scent tracking ability of mosquitoes in environmen-
tally defined three dimensional spaces. US Patent 6,362,235.
7. Carlson DA, Smith N, Gouck HK, Godwin DR (1973) Yellow fever mosquitoes: Com-
pounds related to lactic acid that attract females. J Econ Entomol 66:329–331.
8. Gupta RK, Bhattacharjee AK (2007) Discovery and design of new arthropod/insect
repellents by computer-aided molecular modeling. Insect Repellents: Principles,Meth-
ods, and Uses, eds Debboun M, Frances SP, Strickman D (CRC, Boca Raton, FL), pp
195–228.
9. Hopfield JJ (1984) Neurons with graded response have collective computational prop-
erties like those of two-state neurons. Proc Natl Acad Sci USA 81:3088–3092.
10. Katritzky AR, Karelson M, Petrukhin R (2001) Comprehensive descriptors for structural
and statistical analysis. www.codessa-pro.com.
11. Katritzky AR, Dobchev DA, Tulp I, Karelson M, Carlson DA (2006) QSAR study of
mosquito repellents using CODESSA PRO. Bioorg Med Chem Lett 16:2306–2311.
12. Barnard DR, Bernier UR, Xue RD, Debboun M (2007) Standard methods for testing
mosquito repellents. Insect Repellents: Principles,Methods, andUses, eds Debboun M,
Frances SP, Strickman D (CRC, Boca Raton, FL), pp 103–110.
13. McGovern TP, Beroza M, Gouck HK (1967) Chemicals tested as space repellents for
yellow-fever mosquitoes. II. Carbanilates, benzamides, aliphatic amides, and imides. J
Econ Entomol 60:1591–1594.
14. McGovern TP, et al. (1974) N,N-substituted n-alkanesulfonamides as repellents for the
yellow fever mosquito and the German cockroach. J Econ Entomol 67:71–73.
15. McGovern TP, Schreck CE, Jackson J, Beroza M (1975) n-Acylamides and n-
alkylsulfonamides from heterocyclic amines as repellents for yellow fever mosquitoes.
Mosq News 35:204–210.
16. McGovern TP, Schreck CE, Jackson J (1978) Alicyclic carboxamides from heterocyclic
amines as repellents for Aedes aegypti and Anopheles quadrimaculatus. Mosq News
38:510–514.
17. Schreck CE, McGovern TP, Smith N (1978) Repellency of selected esters and amides of
four alicyclic acids against the stable fly, Stomoxys calcitrans (Diptera: Muscidae). JMed
Entomol 14:589–591.
18. Schreck CE, Smith N, McGovern TP (1979) Repellency of selected compounds against
two species of biting midges (Diptera: Ceratopogonidae: Culicoides). J Med Entomol
16:524–527.
19. McGovern TP, Dame DA, Focks DA, Cameron AL (1980) Laboratory and field evaluation
and structure-activity relationships of some aryl terpenoid ethers as insect growth
regulators against Anopheles quadrimaculatus, Anopheles albimanus, and Aedes
taeniorhynchus. J Econ Entomol 73:443–448.
20. McGovern TP, Schreck CE (1981) Alicyclic piperidine derivatives as insect repellents. US
Patent 4,291,041.
21. McGovern TP, Schreck CE, Jackson J (1984) Mosquito repellents: N,N-dimethylbenz-
amides,N,N-dimethylbenzeneacetamides, and other selectedN,N-dimethylcarboxam-
ides as repellents for Aedes aegypti, Anopheles quadrimaculatus and Anopheles
albimanus. Mosq News 44(1):11–16.
22. Schreck CE, McGovern TP (1985) Repellent tests in the field and laboratory against wild
populations of Mansonia titillans (Diptera: Culicidae). J Med Entomol 22:658–662.
23. McGovern TP, Schreck CE (1988) Mosquito repellents: monocarboxylic esters of ali-
phatic diols. J Am Mosq Control Assoc 4:314–321.
24. Schreck CE, McGovern TP (1989) Repellents and other personal protection strategies
against Aedes albopictus. J Am Mosq Control Assoc 5:247–250.
25. US Department of Agriculture (1954) Chemicals Evaluated as Insecticides and Repel-
lents at Orlando, Fla, compiled by King WV (US Dept Agriculture, Washington, DC),
Agriculture Handbook No 69.
26. US Department of Agriculture (1967) Materials Evaluated as Insecticides, Repellents,
and Chemosterilants at Orlando and Gainesville, Fla, 1952–1964 (US Dept Agriculture,
Washington, DC), Agriculture Handbook No 340.
27. US Department of Agriculture (1977) Repellent activity of compounds submitted by
Walter Reed Army Institute of Research Part I. Protection time andminimum effective
dosage against Aedes aegypti mosquitoes (US Dept Agriculture, Washington, DC),
Technical Bulletin No 1549.
28. Haykin S (1998) Neural Networks: A Comprehensive Foundation (Prentice–Hall, Engle-
wood Cliffs, NJ), 2nd Ed, pp 1–842.
29. Katritzky AR, et al. (2006) QSAR modeling of anti-invasive activity of organic com-
pounds using structural descriptors. Bioorg Med Chem 14:6933–6939.
30. Coan SB, Papa D (1955) Antifungal agents. J Am Chem Soc 77:2402–2404.
31. Lindsay CM, Widdowson DA (1988) Organic synthesis with carbon monoxide: synthesis
of carbamoylstannanes and aromatic carbamoylation. J Chem Soc Perkin Trans 1,
569–573.
32. Montaudo G, Finocchiaro P, Maravigna P, Overberger CG (1972) Conformational
properties of structurally rigid polyamides. Conformation of model diamides. Macro-
molecules 5:197–202.
33. McGovern TP, Burden GS (1984) Cockroach repellents. US patent 6,625,329; (1985)
Chem Abstr 102:144859.
34. House HO, Lee LF (1976) A new synthesis of 2-alkylpyrrolidines and 2-alkylpiperidines.
J Org Chem 41:863–869.
35. Oare DA, Henderson MA, Sanner MA, Heathcock CH (1990) Stereochemistry of the
Michael addition of N,N-disubstituted amide and thioamide enolates to ,-
unsaturated ketones. J Org Chem 55:132–157.
36. Yoshifuji S, Arakawa Y, Nitta Y (1985) Ruthenium tetroxide oxidation of 1-azabicy-
cloalkan-2-ones. Chem Pharm Bull 33:5042–5047.
37. Skau EL, Mod RR, Magne FC (1967) N-Acyl derivatives of cyclic imines as poly(vinyl
chloride) polymer plasticizer. US Patent 3,309,332.
38. Nambu H, Hata K, Matsugi M, Kita Y (2005) Efficient synthesis of thioesters and amides
from aldehydes by using an intermolecular radical reaction in water. Chem Eur J
11:719–727.
39. Katritzky AR, Rachwal S, Hitchings GJ (1991) Benzotriazole: a novel synthetic auxiliary.
Tetrahedron 4:2683–2732.
40. Katritzky AR, Lan X, Fan WQ (1994) Benzotriazole as a synthetic auxiliary: benzotria-
zolylalkylations and benzotriazole-mediated heteroalkylation. Synthesis 445–456.
41. Katritzky AR, Lan X, Yang JZ, Denisko OV (1998) Properties and synthetic utility of
N-substituted benzotriazoles. Chem Rev 98:409–548.
42. Katritzky AR, Rogovoy BV (2003) Benzotriazole: an ideal synthetic auxiliary. Chem Eur
J 9:4586–4593.
43. Katritzky AR, Manju K, Singh SK, Meher NK (2005) Benzotriazole mediated amino-,
amido-, alkoxy- and alkylthio-alkylation. Tetrahedron 61:2555–2581.
44. Katritzky AR, Suzuki K, Wang Z (2005) Acylbenzotriazoles as advantageous N-, C-, S-,
and O-acylating agents. Synlett, 1656–1665.
45. Katritzky AR, Shobana N, Pernak J, Afridi AS, Fan WQ (1992) Sulfonyl derivatives of
benzotriazole. Part 1. A novel approach to the activation of carboxylic acids. Tetrahe-
dron 48:7817–7822.
46. Katritzky AR, He HY, Suzuki K (2000)N-Acylbenzotriazoles: Neutral acylating reagents
for the preparation of primary, secondary, and tertiary amides. J Org Chem 65:8210–
8213.
47. Katritzky AR, Zhang Y, Singh SK (2003) Efficient conversion of carboxylic acids into
N-acylbenzotriazoles. Synthesis, 2795–2798.
48. Katritzky AR, Cai C, Singh SK (2006) Efficient microwave access to polysubstituted
amidines from imidoylbenzotriazoles. J Org Chem 71:3375–3380.
49. Pridgeon JW, et al. (2007) Structure-activity relationships of 33 piperidines as toxicants
against female adults of Aedes aegypti (Diptera: Culicidae). J Med Entomol 44:263–
269.
50. Crown H, ed (1990) Comprehensive Drug Design (Pergamon, New York), pp 1–19.
51. Jones WD, Nguyen TT, Kloss B, Lee KJ, Vosshall LB (2005) Functional conservation of an
insect odorant receptor gene across 250 million years of evolution. Curr Biol 15:119–
121.
52. Posey KH, Schreck CE (1981) An airflow apparatus for selecting female mosquitoes for
use in repellent and attraction studies. Mosq News 41:566–568.
7364  www.pnas.orgcgidoi10.1073pnas.0800571105 Katritzky et al.
Supporting Information
Katritzky et al. 10.1073/pnas.0800571105
SI Text
1H NMR Spectra. Examination of the 1H/13C NMR spectra reveals
that the coalescence temperatures (Tc) for all of the carboxam-
ide-piperidines are above room temperature. Due to the partial
double character of C–N bonds, amides 4a, c–e, h, i, l, p, q, c,
h–k, n, and 4o exist as mixtures of two rotamers in almost
equal proportions at 20°C as depicted in Fig. S2. Amide 4g is a
mixture of cis and trans isomers (1:1), each of which exists also
as a mixture of the two rotamers. Because of the symmetrical
structures in the piperidine rings, molecules 4b, f, g, j, k,m–o, a,
b, d, e, l, m, p , and q are observed as single rotamers at
20°C. The population ratio of the two rotamers was found to be
1:1 in different solvents, such as CDCl3, CDBr3, C6D5CD3, and
C6D6. In the case of amide 4f only one rotamer is observed even
though it is unsymmetrical.
The 1H NMR spectra (Figs. S3–S5) of 4c, e, and k reveal two
sets of signals for the CH3 protons at room temperature.
Similarly, the protons at C-2 and C-6 of the piperidine rings have
different chemical shifts due to differing environments. When
the NMR spectra of 4 c, e, and k were observed at higher
temperatures, the two sets of signals (CH3, H-2 and H-6,
OC–CH2) were seen to coalesce into a single set. This corre-
sponds to an increase in the rate of rotation around the C–N
amide bond causing the environments of CH3, H-2, and H-6 to
become equivalent.
Variable-temperature 1H NMR (Figs. S3-S5) was used to
investigate the amide rotation barriers in all three acylpiperi-
dines 4c, e, and k.
Barriers to Rotation. The equation used to calculate free energies
of activation at coalescence (Table S4), G‡ (kcalmol1) 
4.58  103 Tc[10.32  log(Tc/2.22)], assumes exchange
between equally populated sites with no coupling. For an AB
system, with coupling between the sites, the mean lifetime when
A and B signals coalesce is given by c  21/2[(2  6J2)]1/2.
In general, the effect of coupling to other nuclei on the exchange
rate required to cause coalescence cannot easily be estimated.
The free energy of activation, G‡, was obtained from the
exchange rate at the coalescence temperature, Tc, by application
of the Eyring equation. Ignoring the couplings between the
exchanging sites means that the estimatedG‡ are lower than the
true values. The precision, for the exchange when the couplings
are also accounted for, is 0.3 kcalmol1. The relative values
will be more accurate because the error due to neglect of
coupling is always in the same direction.
General Methods and Materials. Melting points were determined
on a hot-stage apparatus and are uncorrected. NMR spectra
were recorded in CDCl3 with tetramethylsilane as the internal
standard for 1H (300 MHz) or CDCl3 as the internal standard on
a Varian Mercury 300 for 13C (75 MHz), unless otherwise
specified. Elemental and mass spectrometry analyses were per-
formed by Analytical Laboratories, Department of Chemistry,
University of Florida in Gainesville. All reactions were carried
out under an atmosphere of nitrogen. Anhydrous THF was
obtained by distillation immediately before use, from sodium/
benzophenone ketyl. Column chromatography was performed
with S733–1 silica gel (200–425 mesh; Fisher Scientific).
General Procedure for the Preparation of N-acylpiperidines 4a–4q.
1-Acylbenzotriazole (2a–2q, 38.0 mmol) was stirred with a
piperidine (3a–3f, 38.0 mmol) in THF (200 ml) at room tem-
perature for 4–72 h or in dry toluene (200 ml) under reflux for
8–24 h. After evaporation of solvent in a vacuum, the residue was
added to 1 M Na2CO3 (100 ml) and the mixture was extracted
with ethyl acetate (120 ml). The combined organic layers were
dried over anhydrous MgSO4. Evaporation of the solvent gave
pure N-acylpiperidines (4b–g, i–k, m–e, j–n, p, q). Further
purification of the residues of the remaining compounds by
column chromatography on silica gel using a mixture of hexanes
and ethyl acetate as gradient eluant gave the corresponding
N-acylpiperidines (4a, h, l, f, g, h, i, o).
N-acylpiperidines 4a–4q. 1-Acetyl -2-methylpiperidine (4a). Colorless
oil (1); after chromatography on silica gel using hexanes/ethyl
acetate as eluant (100/1 to 2/1, vol/vol); yield 71%; (mixture of
two rotamers): 1H NMR (CDCl3)  4.91 (br s, 1H), 4.49 (d, J 
13.3 Hz, 1H), 4.08 (br s, 1H), 3.58 (d, J  13.5, 1H), 3.15 (t, J 
13.3 Hz, 1H), 2.63 (t, J  13.4 Hz, 1H), 2.07 (d, J  7.6 Hz, 6H),
1.69–1.12 (m, 18H); 13C NMR (CDCl3)  168.8, 49.0, 43.4, 41.5,
36.0, 30.6, 29.7, 26.1, 25.3, 21.9, 21.3, 18.6, 16.4, 15.4. Anal. Calcd
for C8H15NO: C, 68.05; H, 10.71; N, 9.92. Found: C, 67.68; H,
10.97; N, 10.18.
1-(1-Oxopropyl)piperidine (4b).Colorless oil (2); yield 84%; 1HNMR
(CDCl3)  3.55 (t, J  5.4 Hz, 2H), 3.39 (t, J  5.4 Hz, 2H), 2.34
(q, J  7.5, 2H), 1.64–1.53 (m, 6H), 1.14 (t, J  7.5, 3H); 13C
NMR (CDCl3)  172.0, 46.4, 42.5, 26.5, 26.4, 25.5, 24.5, 9.5.
2-Ethyl-1-(1-oxopropyl)piperidine (4c). Colorless oil (3); yield 75%;
(mixture of two rotamers): 1H NMR (CDCl3)  4.71 (br s, 1H),
4.57–4.53 (m, 1H), 3.81 (br s, 1H), 3.65–3.60 (m, 1H), 3.09–3.00
(m, 1H), 2.62–2.52 (m, 1H), 2.40–2.29 (m, 4H), 1.79–1.31 (m,
16H), 1.17–1.08 (m, 6H), 0.98–0.82 (m, 6H); 13C NMR (CDCl3)
 172.4, 172.3, 54.1, 49.1, 40.7, 36.2, 28.7, 27.5, 26.9, 26.5, 26.3,
25.4, 22.8, 22.1, 19.0, 10.8, 10.6, 9.7, 9.7. Anal. Calcd for
C10H19NO: C, 70.96; H, 11.31; N, 8.27. Found: C, 70.97; H, 11.44;
N, 8.75.
2-Methyl-1-(1-oxoheptyl)-piperidine (4d). colorless oil (4); yield 88%;
(mixture of two rotamers): 1H NMR (CDCl3)  4.93 (br s, 1H),
4.51 (d, J  13.5 Hz, 1H), 4.14 (br s, 1H), 3.63 (d, J  13.0 Hz,
1H), 3.11 (t, J 12.5 Hz, 1H), 2.64 (t, J 12.6 Hz, 1H), 2.37–2.26
(m, 4H), 1.69–1.46 (m, 14H), 1.38–1.10 (m, 20H), 0.91–0.86 (m,
6H); 13C NMR (CDCl3)  171.3, 53.2, 47.9, 43.1, 40.5, 35.7, 33.7,
33.1, 31.4, 30.5, 29.5, 28.9, 26.1, 25.3, 22.3, 18.5, 16.4, 15.2, 13.8.
Anal. Calcd for C13H25NO: C, 73.88; H, 11.92; N, 6.63. Found:
C, 73.88; H, 12.34; N, 6.93.
3-Methyl-1-(1-oxoheptyl)piperidine (4e). colorless oil (4); yield 76%;
(mixture of two rotamers): 1H NMR (CDCl3)  4.44 (d, J  12.6
Hz, 2H), 3.79–3.66 (m, 2H), 2.99–2.90 (m, 1H), 2.70–2.55 (m,
2H), 2.34–2.17 (m, 5H), 1.84–1.80 (m, 2H), 1.75–1.22 (m, 22H),
1.20–1.05 (m, 2H), 0.96–0.82 (m, 12H); 13C NMR (CDCl3) 
171.3, 171.2, 53.1, 48.8, 46.0, 41.9, 33.4, 33.2, 32.9, 32.9, 31.7, 31.5,
31.5, 30.8, 29.0, 25.9, 25.3, 25.3, 24.6, 22.4, 18.9, 18.8, 13.9, 13.9.
4-Methyl-1-(1-oxooctyl)piperidine (4f).Colorless oil (4); yield 77%; 1H
NMR (CDCl3)  4.64–4.53 (m, 1H), 3.86–3.76 (m, 1H), 2.98 (td,
J  12.9, 2.4 Hz, 1H), 2.52 (td, J  12.9, 2.3 Hz, 1H), 2.31 (t, J 
7.7 Hz, 2H), 1.73–1.51 (m, 5H), 1.37–1.22 (m, 8H), 1.15–1.00 (m,
2H), 0.95 (d, J  6.3 Hz, 3H), 0.90–0.84 (m, 3H); 13C NMR
(CDCl3)  171.5, 46.0, 41.9, 34.7, 33.8, 33.5, 31.7, 31.1, 29.5, 29.1,
25.5, 22.6, 21.7, 14.1. Anal. Calcd for C14H27NO: C, 74.61; H,
12.07; N, 6.21. Found: C, 74.56; H, 12.44; N, 6.65.
1-(1-Oxooctyl)-4-(phenylmethyl)piperidine (4g). Colorless oil; yield
76%; 1H NMR (CDCl3)  7.32–7.26 (m, 2H), 7.23–7.17 (m, 1H),
7.15–7.12 (m, 2H), 4.61 (dt, J  13.2, 1.9 Hz, 1H), 3.8 (d, 13.5,
1H), 2.93 (td, J 13.0, 2.0 Hz, 1H), 2.56–2.42 (m, 3H) 2.32–2.27
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(m, 2H), 1.79–1.55 (m, 5H), 1.30–1.07 (m, 10H), 0.88 (t, J  6.7
Hz, 3H); 13C NMR (CDCl3)  171.5, 139.9, 129.0, 128.2, 126.0,
45.9, 42.9, 41.8, 38.3, 33.5, 32.6, 31.8, 31.7, 29.4, 29.0, 25.4, 22.6,
14.1. Anal. Calcd for C20H31NO: C, 79.68; H, 10.36; N, 4.65.
Found: C, 79.94; H, 10.77; N, 5.01.
2-Ethyl-1-(1-oxononyl)piperidine (4h). Colorless oil (4) after chroma-
tography on silica gel using hexanes/ethyl acetate as eluant (80/1
to 40/1, vol/vol); yield 83%; (mixture of two rotamers): 1H NMR
(CDCl3)  4.71 (br s, 1H), 4.55 (dd, J  13.2, 3.4 Hz, 1H), 3.81
(br s, 1H), 3.65–3.61 (m, 1H), 3.09–3.00 (m, 1H), 2.60–2.51 (m,
1H), 2.40–2.21 (m, 4H), 1.81–1.47 (m, 16H), 1.44–1.27 (m, 24H),
0.98–0.81 (m, 12H); 13C NMR (CDCl3)  171.9, 54.3, 49.0, 41.0,
36.2, 33.9, 33.4, 31.8, 29.5, 29.3, 29.1, 28.8, 27.6, 26.4, 25.5, 25.4,
22.9, 22.6, 22.1, 19.0, 14.0, 10.8, 10.6.
2-Methyl-1-(1-oxodecyl)piperidine (4i). Colorless oil (5); yield 92%;
(mixture of two rotamers): 1H NMR (CDCl3)  4.94 (br s, 1H),
4.52 (d, J  11.9 Hz, 1H), 4.14 (br s, 1H), 3.62 (d, J  13.0 Hz,
1H), 3.11 (t, J  13.1, 1H), 2.64 (t, J  12.6 Hz, 1H), 2.36–2.25
(m, 4H), 1.72–1.48 (m, 14H), 1.45–1.12 (m, 32H), 0.90-O.85 (m,
6H); 13C NMR (CDCl3)  17.6, 171.5, 146.1, 130.2, 126.0, 120.0,
114.4, 48.1, 43.3, 40.7, 35.9, 35.4, 33.9, 33.4, 31.8, 31.8, 30.7, 29.7,
29.5, 29.4, 29.3, 29.2, 29.2, 29.0, 26.3, 25.5, 24.3, 22.6, 18.7, 15.4,
14.0.
4-Methyl-1-(1-oxodecyl)piperidine (4j). Colorless oil (4); yield 83%;
1H NMR (CDCl3)  4.62 (dd, J  13.2, 1.8 Hz, 1H), 3.85 (d, J 
12.1 Hz, 1H), 3.01 (td, J  12.8, 2.3 Hz, 1H), 2.55 (td, J  12.8,
2.3 Hz, 1H), 2.34 (t, J 7.8 Hz, 2H), 1.73–1.58 (m, 5H), 1.33–1.30
(m, 12H), 1.18–0.89 (m, 8H); 13C NMR (CDCl3)  171.5, 45.9,
41.9, 34.7, 33.8, 33.5, 31.8, 31.1, 29.5, 29.4, 29.4, 29.2, 25.5, 22.6,
21.7, 14.1.
1-(1-Oxo-10-undecylenyl)piperidine (4k). Colorless oil (6); yield 83%;
1H NMR (CDCl3)  5.88–5.75 (m, 1H), 5.02–4.91 (m, 2H), 3.55
(t, J  5.4 Hz, 2H), 3.39 (t, J  5.3 Hz, 2H), 2.31 (t, J  7.8 Hz,
2H), 2.07–2.00 (m, 2H), 1.67–1.50 (m, 8H), 1.39–1.23 (m, 10H);
13C NMR (CDCl3)  171.5, 139.2, 114.1, 46.7, 42.5, 33.7, 33.4,
29.5, 29.4, 29.3, 29.0, 28.9, 26.5, 25.5, 25.4, 24.6. Anal. Calcd for
C16H29NO: C, 76.44; H, 11.63; N, 5.57. Found: C, 76.58; H, 12.02;
H, 5.85.
2-Ethyl-1-(1-oxo-10-undecylenyl)piperidine (4l). Colorless oil after
chromatography on silica gel using hexanes/ethyl acetate as
eluant (80/1 to 40/1, vol/vol); yield 90%; (mixture of two rota-
mers): 1H NMR (CDCl3)  5.88–5.74 (m, 2H), 5.03–4.91 (m,
4H), 4.51 (d, J  12.8 Hz, 1H), 4.14 (br s, 1H), 3.62 (d, J  12.8
Hz, 1H), 3.11 (t, J  12.6 Hz, 1H), 2.64 (t, J  12.6 Hz, 1H),
2.42–2.20 (m, 4H), 2.04 (q, J  7.0 Hz, 4H), 1.69–1.52 (m, 16H),
1.42–1.12 (m, 31H); 13C NMR (CDCl3)  171.5, 139.1, 114.0,
48.1, 43.3, 40.7, 36.0, 33.9, 33.7, 33.4, 30.7, 29.7, 29.5, 29.3, 29.3,
29.0, 28.8, 26.3, 25.5, 25.4, 18.7, 16.6, 15.4. Anal. Calcd for
C18H33NO: C, 77.36; H, 11.90; N, 5.01. Found: C, 77.58; H, 12.29;
N, 5.49.
1-(1-Oxo-10-undecylenyl)-4-(phenylmethyl)piperidine (4m). Colorless
oil; yield 76%; 1H NMR (CDCl3)  7.37–7.17 (m, 5H), 5.93–5.79
(m, 1H), 5.08–4.96 (m, 2H), 4.66 (d, J  11.4 Hz, 1H), 3.87 (d,
J  13.5 Hz, 1H), 3.02–2.93 (m, 1H), 2.61–2.47 (m, 3H), 2.35 (t,
J  7.7 Hz, 2H), 2.09 (q, J  7.0 Hz, 2H), 1.84–1.60 (m, 5H),
1.44–1.12 (m, 12H); 13C NMR (CDCl3)  171.4, 139.9, 139.2,
129.0, 128.2, 126.0, 114.1, 45.9, 42.9, 41.8, 38.2, 33.7, 33.5, 32.6,
31.8, 29.5, 29.3, 29.3, 29.0, 28.8, 25.4. Anal. Calcd for C23H35NO:
C, 80.88; H, 10.33; N, 4.10. Found: C, 81.25; H, 10.71; N, 4.49.
4-Methyl-1-(1-oxo-10-undecylenyl)piperidine (4n). Colorless oil; yield
76%; 1H NMR (CDCl3)  5.87–5.74 (m, 1H), 5.03–4.91 (m, 2H),
4.61–4.56 (m, 1H), 3.84–3.79 (m, 1H), 2.98 (td, J  13.0, 2.4 Hz,
1H), 2.52 (td, J 12.8, 2.4 Hz, 1H), 2.31 (t, J 7.8 Hz, 2H), 2.03
(q, J  7.0 Hz, 2H), 1.73–1.51 (m, 5H), 1.42–1.23 (m, 10H),
1.15–0.99 (m, 2H), 0.95 (d, J  6.5 Hz, 3H); 13C NMR (CDCl3)
 171.4, 139.1, 114.1, 45.9, 41.9, 34.7, 33.8, 33.7, 33.5, 31.1, 29.4,
29.3, 29.3, 29.0, 28.8, 25.4, 21.7. Anal. Calcd for C17H31NO: C,
76.92; H, 11.77; N, 5.28. Found: C, 76.85; H, 11.91; N, 5.58.
1-(1-Oxoundecyl)piperidine (4o). Colorless oil (7); yield 92%; 1H
NMR (CDCl3)  3.57–3.53 (m, 2H), 3.41–3.38 (m, 2H), 2.31 (t,
J  7.8 Hz, 2H), 1.64–1.53 (m, 8H) 1.38–1.18 (m, 14H), 0.88 (t,
J 6.7 Hz, 3H); 13C NMR (CDCl3)  171.5, 46.7, 42.5, 33.5, 31.8,
29.5, 29.5, 29.5, 29.4, 29.3, 26.5, 25.5, 25.5, 24.5, 22.6, 14.1.
2-Methyl-1-(1-oxododecyl)piperidine (4p).Colorless oil (8); yield 77%;
(mixture of two rotamers): 1H NMR (CDCl3)  4.94 (br s, 1H),
4.51 (d, J  12.9 Hz, 1H), 4.14 (br s, 1H), 3.63 (d, J  11.9 Hz,
1H), 3.11 (t, J 13.0 Hz, 1H), 2.64 (t, J 13.3 Hz, 1H), 2.34–2.26
(m, 4H), 1.70–1.50 (m, 14H), 1.40–1.12 (m, 40H), 0.88 (t, J 6.7
Hz, 6H); 13C NMR (CDCl3)  171.4, 48.0, 43.2, 40.6, 35.8, 33.7,
33.2, 31.7, 30.6, 29.4, 29.3, 29.3, 29.1, 26.2, 25.3, 22.5, 18.6, 16.4,
15.3, 13.9.
3-Methyl-1-(1-oxododecanyl)piperidine (4q). Colorless oil (8); yield
92%; (mixture of two rotamers): 1H NMR (CDCl3)  4.49–4.38
(m, 2H), 3.80–3.63 (m, 2H), 2.99–2.88 (m, 1H), 2.69–2.54 (m,
2H), 2.31 (t, J  7.8 Hz, 4H), 2.25–2.17 (m, 1H), 1.90–1.78 (m,
2H), 1.76–1.50 (m, 8H), 1.50–1.05 (m, 36H), 0.93–0.84 (m, 12H);
13C NMR (CDCl3)  171.4, 171.4, 53.2, 48.9, 46.1, 42.0, 33.5, 33.4,
33.1, 33.0, 31.8, 31.8, 30.9, 29.5, 29.4, 29.4, 29.3, 26.0, 25.5, 25.4,
24.7, 22.6, 19.0, 18.9, 14.0. Anal. Calcd for C18H35NO: C, 76.80;
H, 12.53; N, 4.98. Found: C, 76.95; H, 12.96; N, 5.27.
1-(1-Cyclohexen-1-ylcarbonyl)piperidine (4a). Colorless oil (9); yield
98%; 1H NMR (CDCl3)  5.78–5.75 (m, 1H), 3.49 (br s, 4H),
2.18–2.08 (m, 4H), 1.74–1.54 (m, 10H); 13C NMR (CDCl3) 
171.7, 134.7, 126.6, 47.9 (br), 42.6 (br), 26.0, 24.7, 24.5, 22.1, 21.6.
Anal. Calcd for C12H19NO: C, 74.57; H, 9.91; N, 7.25. Found: C,
74.18; H, 10.16; N, 7.68.
1-(Cyclohexylcarbonyl)piperidine (4b). Colorless oil (10); yield 97%;
1H NMR (CDCl3)  3.55 (t, J  5.3 Hz, 2H), 3.43 (t, J  4.8 Hz,
2H), 2.52–2.42 (m, 1H), 1.85–1.45 (m, 13H), 1.35–1.18 (m, 3H);
13C NMR (CDCl3)  174.3, 46.3, 42.6, 40.4, 29.4 (2C), 26.8, 25.9
(2C), 25.8, 25.6, 24.6.
1-(Cyclohexylcarbonyl)-3-methylpiperidine (4c). Yellow oil (11); yield
100%; (mixture of two rotamers): 1H NMR (CDCl3)  4.49–4.42
(m, 2H), 3.84–3.71 (m, 2H), 2.99–2.90 (m, 1H), 2.68–2.43 (m,
4H), 2.25–2.18 (m, 1H), 1.85–1.06 (m, 30H), 0.94–0.88 (m, 6H);
13C NMR (CDCl3)  168.8, 49.0, 43.4, 41.5, 36.0, 30.6, 29.7, 26.1,
25.3, 21.9, 21.3, 18.6, 16.4, 15.4. Anal. Calcd for C13H23NO: C,
74.59; H, 11.07; N, 6.69. Found: C, 74.23; H, 11.41; N, 7.01.
1-(Cyclohexylcarbonyl)-4-methylpiperidine (4d). Yellow oil (11); yield
99%; 1H NMR (CDCl3)  4.60 (d, J  13.3 Hz, 1H), 3.88 (d, J 
13.9 Hz, 1H), 2.97 (td, J  12.9, 2.1 Hz, 1H), 2.58–2.40 (m, 2H),
1.88–1.40 (m, 10H), 1.36–1.18 (m, 3H), 1.16–1.00 (m, 2H),
0.99–0.88 (m, 3H); 13C NMR (CDCl3)  174.3, 45.6, 41.9, 40.4,
35.0, 33.8, 31.2, 29.5, 29.2, 25.8, 25.8, 21.7.
1-(3-Cyclopentyl-1-oxopropyl)piperidine (4e). Yellow oil (8); yield
97%; 1H NMR (CDCl3)  3.56–3.53 (m, 2H), 3.42–3.38 (m, 2H),
2.36–2.30 (m, 2H), 1.82–1.72 (m, 3H), 1.69–1.45 (m, 12H),
1.20–1.04 (m, 2H); 13C NMR (CDCl3)  171.5, 46.7, 42.5, 39.9,
32.7, 32.5, 31.7, 26.5, 25.5, 25.1, 24.6.
1-(1-Methylcyclohexylcarbonyl)-3-methylpiperidine (4f). Colorless oil
after chromatography on silica gel using hexanes/ethyl acetate as
eluant (80/1 to 5/1, vol/vol); yield 71%; 1H NMR (CDCl3)  4.30
(t, J  16.2 Hz, 2H), 2.71 (t, J  12.6 Hz, 1H), 2.39 (t, J  11.7
Hz, 1H), 2.05–1.99 (m, 2H), 1.86–1.80 (m, 1H), 1.70–0.91 (m,
12H), 1.23 (s, 3H), 0.89 (d, J  6.6 Hz, 3H); 13C NMR (CDCl3)
 175.4, 52.7, 46.0, 42.6, 37.2 (2C), 33.4, 31.5, 25.9, 25.7, 24.3, 23.1
(2C), 19.0. Anal. Calcd for C14H25NO: C, 75.28; H, 11.28; N, 6.27.
Found: C, 74.97; H, 11.69; N, 6.54.
2-Methyl-1-[(4-methylcyclohexyl)carbonyl]piperidine (4g). Mixture of
cis and trans; colorless oil (8) after chromatography on silica gel
using hexanes/ethyl acetate as eluant (100/1 to 9/1, vol/vol); yield
86%; (mixture of two rotamers for each geometric isomer): 1H
NMR (CDCl3)  4.94 (br s, 1H), 4.60–4.42 (m, 1H), 4.19 (br s,
1H), 3.74–3.59 (m, 1H), 3.10 (t, J  12.0 Hz, 1H), 2.74–2.30 (m,
3H), 1.90–1.04 (m, 34H), 1.02–0.84 (m, 8H); 13C NMR (CDCl3)
 174.6, 174.6, 174.5, 174.5, 174.4, 47.8, 43.3, 40.4, 39.2, 36.0, 34.5,
Katritzky et al. www.pnas.org/cgi/content/short/0800571105 2 of 18
32.0, 31.1, 30.9, 30.1, 29.8, 29.4, 29.2, 29.0, 28.3, 26.6, 25.6, 25.0,
24.5, 22.6, 18.8, 17.0, 15.4.
1-(Cyclohexylcarbonyl)-2-ethylpiperididne (4h).Colorless oil (11) after
chromatography on silica gel using hexanes/ethyl acetate as
eluant (80/1 to 8/1, vol/vol); yield 75%; (mixture of two rotam-
ers): 1H NMR (CDCl3)  4.72 (br s, 1H), 4.55 (d, J  13.3 Hz,
1H), 3.87 (br s, 1H), 3.70 (d, J  12.9 Hz, 1H), 3.04 (t, J  11.7
Hz, 1H), 2.58–2.43 (m, 3H), 1.90–1.20 (m, 36H), 0.92–0.79 (m,
6H); 13C NMR (CDCl3)  175.1, 174.7, 53.8, 48.9, 40.7, 40.6, 40.5,
36.2, 30.2, 29.5, 29.3, 29.1, 29.0, 28.9, 27.7, 26.6, 26.1, 25.9, 25.8,
25.7, 25.5, 25.4, 23.0, 22.2, 19.1, 10.8, 10.5. Anal. Calcd for
C14H25NO: C, 75.28; H, 11.28; N, 6.27. Found: C, 75.59; H, 11.65;
N, 6.67.
1-(Cyclohexylacetyl)-2-methylpiperidine (4i). Colorless oil (11) after
chromatography on silica gel using hexanes/ethyl acetate as
eluant (80/1–9/1, vol/vol); yield 72%; (mixture of two rotamers):
1H NMR (CDCl3)  4.96 (br s, 1H), 4.53 (d, J  12.8 Hz, 1H),
4.17 (br s, 1H), 3.66 (d, J  12.8 Hz, 1H), 3.11 (t, J  13.5 Hz,
1H), 2.64 (t, J  12.8 Hz, 1H), 2.33–2.06 (m, 4H), 1.88–1.46 (m,
22H), 1.45–1.05 (m, 14H), 1.04–0.90 (m, 4H); 13C NMR (CDCl3)
 170.8, 48.3, 43.3, 41.2, 41.0, 40.8, 36.0, 35.2, 33.3, 30.8, 29.8, 26.4,
26.2, 26.1, 26.1, 25.6, 18.7, 16.7, 15.5. Anal. Calcd for C14H25NO:
C, 75.28; H, 11.28; N, 6.27. Found: C, 75.39; H, 11.67; N, 6.68.
1-(3-Cyclohexyl-1-oxopropyl)-2-methylpiperidine (4j). Yellow oil (11);
yield 94%; (mixture of two rotamers): 1H NMR (CDCl3)  4.92
(br s, 1H), 4.51 (d, J  10.7 Hz, 1H), 4.14 (br s, 1H), 3.62 (d, J 
13.5 Hz, 1H), 3.11 (t, J 12.0 Hz, 1H), 2.64 (t, J 13.1 Hz, 1H),
2.44–2.20 (m, 4H), 1.78–1.06 (m, 40H), 0.99–0.83 (m, 4H); 13C
NMR (CDCl3)  171.8, 48.2, 43.3, 40.7, 37.5, 36.0, 33.1, 33.1, 32.8,
31.4, 30.9, 30.7, 29.7, 26.5, 26.3, 26.2, 25.5, 18.7, 16.6, 15.4.
1-(3-Cyclohexyl-1-oxopropyl)-3-methylpiperidine (4k). Colorless oil
(11); yield 100%; (mixture of two rotamers): 1H NMR (CDCl3)
 4.44 (d, J 12.8 Hz, 2H), 3.77–3.65 (m, 2H), 2.98–2.89 (m, 1H),
2.69–2.53 (m, 2H), 2.53–2.30 (m, 4H), 2.21 (t, J  11.9 Hz, 1H),
1.86–1.32 (m 22H), 1.31–1.03 (m 10H), 0.97–0.88 (m, 10H); 13C
NMR (CDCl3)  171.7, 171.6, 53.2, 48.9, 46.1, 42.0, 37.4, 37.4,
33.0, 33.0, 32.9, 32.8, 31.8, 31.0, 30.9, 30.8, 26.5, 26.2, 26.0, 24.7,
19.0, 18.9.
1-(3-Cyclohexyl-1-oxopropyl)-4-methylpiperidine (4l). Yellow oil (11);
yield 96%; 1H NMR (CDCl3)  4.61 (d, J  11.8 Hz, 1H), 3.84
(d, J  13.0 Hz, 1H), 3.01 (t, J  11.6 Hz, 1H), 2.55 (t, J  12.6
Hz, 1H), 2.38–2.33 (m, 2H), 1.80–1.48 (m, 10H), 1.35–0.85 (m,
11H); 13C NMR (CDCl3)  171.8, 45.9, 41.9, 37.5, 34.7, 33.8, 33.1,
32.9, 31.1, 31.0, 26.5, 26.2, 21.7.
1-(3-Cyclohexyl-1-oxopropyl)-4-methylpiperidine (4m). Colorless oil
(11); yield 100%; 1H NMR (CDCl3)  4.61 (d, J  11.8 Hz, 1H),
3.84 (d, J  13.0 Hz, 1H), 3.01 (t, J  11.6 Hz, 1H), 2.55 (t, J 
12.6 Hz, 1H), 2.38–2.33 (m, 2H), 1.80–1.48 (m, 10H), 1.35–0.85
(m, 11H); 13C NMR (CDCl3)  171.8, 45.9, 41.9, 37.5, 34.7, 33.8,
33.1, 32.9, 31.1, 31.0, 26.5, 26.2, 21.7.
1-(3-Cyclopentyl-1-oxopropyl)-2-ethylpiperidine (4n). Brown oil; yield
98%; (mixture of two rotamers): 1H NMR (CDCl3)  4.90 (br s,
1H), 4.74 (dd, J  14.7, 3.3 Hz, 1H), 4.01 (br s, 1H), 3.82 (d, J 
11.2 Hz, 1H), 3.24 (td, J 13.0, 1.8 Hz, 1H), 2.74 (t, J 13.0 Hz,
1H), 2.64–2.40 (m, 4H), 2.10–1.42 (m, 34H), 1.40–1.18 (m, 4H),
1.15–1.00 (m, 6H); 13C NMR (CDCl3)  172.0, 171.9, 54.3, 49.0,
41.0, 39.9, 36.2, 33.2, 32.7, 32.5, 31.8, 31.8, 28.8, 27.6, 26.4, 25.4,
25.1, 22.9, 22.1, 19.0, 10.8, 10.6. Direct insertion probe/chemical
ionization/mass spectrometry (DIP-CI-MS), Calcd for
C15H28ON [MH] using methane as a chemical ionization
reagent: m/z 238.2171. Found: 238.2159.
1-(3-Cyclohexyl-1-oxopropyl)-2-ethylpiperidine (4o). Yellow oil (11);
yield 93%; (mixture of two rotamers): 1H NMR (CDCl3)  4.70
(br s, 1H), 4.55 (dd, J  13.2, 3.0 Hz, 1H), 3.81 (br s, 1H), 3.62
(d, J  11.1 Hz, 1H), 3.05 (t, J  13.5, 2.4 Hz, 1H), 2.55 (t, J 
12.6 Hz, 1H), 2.43–2.22 (m, 4H), 1.85–1.36 (m, 30H), 1.32–1.08
(m, 8H), 1.05–0.81 (m, 10H); 13C NMR (CDCl3)  172.2, 172.1,
54.3, 49.0, 41.0, 37.5, 36.2, 33.2, 33.1, 33.0, 31.4, 31.0, 28.8, 27.6,
26.5, 26.4, 26.2, 25.5, 22.9, 22.2, 19.0, 10.9, 10.6.
1-(Cyclohexylacetyl)-4-(phenylmethyl)piperidine (4p).Off-white micro-
crystals; mp 50–52°C; yield 100%; 1H NMR (CDCl3)  7.29 (t,
J 7.1 Hz, 2H), 7.20 (t, J 7.3 Hz, 1H), 7.13 (d, J 7.0 Hz, 2H),
4.63 (d, J  13.5 Hz, 1H), 3.84 (d, J  13.5 Hz, 1H), 2.97–2.88
(m, 1H), 2.60–2.42 (m, 3H), 2.20 (d, J  6.7 Hz, 2H), 1.85–1.55
(m, 9H), 1.33–1.05 (m, 5H), 1.03–0.87 (m, 2H); 13C NMR
(CDCl3)  170.7, 139.9, 129.0, 128.2, 125.9, 46.2, 42.9, 41.8, 40.8,
38.2, 38.2, 35.1, 33.4, 33.3, 32.7, 31.8, 26.2, 26.1. Anal. Calcd for
C20H29NO: C, 80.22; H, 9.76; N, 4.65. Found: C, 79.85; H, 9.92;
N, 5.10.
1-(3-Cyclohexyl-1-oxopropyl)-4-(phenylmethyl)piperidine (4q). Yellow
oil; yield 99%; 1H NMR (CDCl3)  7.32–7.24 (m, 2H), 7.23–7.16
(m, 1H), 7.16–7.10 (m, 2H) 4.60 (d, J  13.4 Hz, 1H), 3.81 (d,
J  13.9 Hz, 1H), 2.93 (td, J  13.1, 2.3 Hz, 1H), 2.60–2.40 (m,
3H), 2.34–2.28 (m, 2H), 1.80–1.60 (m, 8H), 1.54–1.46 (m, 2H),
1.30–1.08 (m, 6H), 0.95–0.83 (m, 2H); 13C NMR (CDCl3) 
171.8, 139.9, 129.0, 128.2, 125.9, 45.9, 42.9, 41.8, 38.2, 37.4, 33.1,
32.8, 32.6, 31.7, 31.0, 26.5, 26.2. Anal. Calcd for C21H31NO: C,
80.46; H, 9.97; N, 4.47. Found: C, 80.61; H, 10.29; N, 4.73.
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Fig. S1. Confusion matrix of predicted versus experimental classes using ANN model for the training subset.
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Fig. S2. Amide rotation in acylpiperidines 4c, 4e, and 4k.
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Fig. S3. Temperature-dependent 1H NMR spectra of 4c.
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Fig. S4. Temperature-dependent 1H NMR spectra of 4e.
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Fig. S5. Temperature-dependent 1H NMR spectra of 4k.
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Table S1. Experimental and predicted classes of repellency according to the ANN model (see Fig. S1)
ID Entry R R Experimental class Predicted class
37495 1 C10H21 2-CH3 1 1
05550* 2 C6H5 H 5 4
06328* 3 (CH3)2CHCH2OOC(CH2)2 H 1 1
08009* 4 C11H23 H 1 1
11533* 5 CH3 H 2 2
14061* 6 2-Cl-C6H4 H 1 1
15132* 7 C6H5CH2 H 2 5
15202* 8 3,4-Cl-C6H3 H 1 1
15496* 9 2,4-Cl-C6H3 H 1 1
16139* 10 C2H5O H 2 2
17017* 11 4-CH3O-C6H4 H 1 2
20364* 12 2-CH3C(O)-C6H4 H 1 1
20365* 13 4-CH3C(O)-C6H4 H 1 1
23151* 14 (CH3)2C(H)O H 1 2
23545* 15 ClCH2 H 3 3
25921* 16 C5H11CH(C2H5) H 1 4
26189* 17 C2H5OOC H 2 4
26783* 18 3,5-CH3-C6H3 H 1 3
26785* 19 3-PiperidinoC(O)-C6H4 H 1 1
26948* 20 3-CH3-C6H4 2-C2H5 1 2
26953* 21 (CH3)3C H 1 4
26959* 22 3-CH3O-C6H4 H 1 2
28563* 23 3-CH3-C6H4 2-C3H7 1 1
28564* 24 3-CH3-C6H4 4-C3H7 1 1
28800* 25 C6H5 2-CH3 1 4
28801* 26 C6H5 4-CH3 1 4
30566* 27 C6H5CH2O H 1 3
30720* 28 Naphth-1-yl H 1 1
31640* 29 4-CH3-C6H4 H 1 4
31641* 30 2-CH3-C6H4 H 2 4
31642* 31 3-CH3-C6H4 H 4 4
32826* 32 C7H15 H 5 5
32827* 33 C8H17 H 5 5
32828* 34 C13H27 H 1 1
32829* 35 C8H17CHCHC7H14 H 1 1
32830 36 PiperidinoC(O)-C8H16 H 1 1
32831 37 PiperidinoC(O)-C7H14 H 1 1
32837 38 PiperidinoC(O)-C4H8 H 1 1
32848 39 C5H11 H 4 3
32850 40 C15H31 H 1 1
33510 41 C6H13 H 5 4
33511 42 C9H19 H 5 5
35462 43 C4H9 H 3 3
35468 44 C3H7 H 2 2
35643 45 C5H11 2-C2H5 5 5
35644 46 C6H13 2-C2H5 5 4
35645 47 C7H15 2-C2H5 5 4
35646 48 C8H17 2-C2H5 2 4
35647 49 C9H19 2-C2H5 1 1
35759 50 ClCH2(CH2)2 H 2 3
35765 51 3-Cyclohexenyl H 5 4
36156 52 (E)-CH3CHC(CH3) H 3 2
36158 53 (E)-CH3CHC(CH3) 2-CH3 4 3
36159 54 (E)-CH3CHC(CH3) 3-CH3 3 3
36160 55 (E)-CH3CHC(CH3) 4-CH3 3 3
36161 56 (E)-CH3CHC(CH3) 2-C2H5 4 4
36170 57 (CH3)2CCH H 2 2
36172 58 (CH3)2CCH 2-CH3 3 3
36173 59 (CH3)2CCH 3-CH3 3 3
36174 60 (CH3)2CCH 4-CH3 3 2
36175 61 (CH3)2CCH 2-C2H5 4 4
36302 62 ClCH2 2-CH3 3 3
36303 63 ClCH2 3-CH3 3 3
36304 64 ClCH2 4-CH3 3 2
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ID Entry R R Experimental class Predicted class
36305 65 ClCH2 2-C2H5 3 3
36324 66 c-C6H11 H 5 5
36335 67 2-C2H5O-C6H4 2-C2H5 4 2
36337 68 2-C2H5O-C6H4 4-CH3 2 2
36338 69 2-C2H5O-C6H4 2-CH3 1 2
36340 70 2-C2H5O-C6H4 3-CH3 3 3
36392 71 CH3CH(OH) 4-CH3 4 3
36536 72 c-C6H11 2-CH3 5 5
36537 73 c-C6H11 3-CH3 5 5
36538 74 c-C6H11 4-CH3 5 5
36539 75 c-C6H11 2-C2H5 5 5
36693 76 C3H7 3-C(O)N(C2H5)2 1 1
36702 77 c-C6H11 3-C(O)N(C2H5)2 1 1
36746 78 CH3 4-CH2-C6H5 5 5
36747 79 C2H5 4-CH2-C6H5 5 4
37086 80 C2H5CH(CH3) H 2 2
37090 81 C2H5CH(CH3) 4-CH3 2 3
37128 82 C3H7CH(CH3) H 4 3
37132 83 C3H7CH(CH3) 4-CH3 2 4
37156 84 C3H7 4-CH2-C6H5 4 4
37157 85 (CH3)2CH 4-CH2-C6H5 2 2
37158 86 C4H9 4-CH2-C6H5 2 2
37159 87 (CH3)2CHCH2 4-CH2-C6H5 2 2
37160 88 C2H5CH(CH3) 4-CH2-C6H5 3 2
37161 89 C5H11 4-CH2-C6H5 1 2
37162 90 c-C6H11 4-CH2-C6H5 1 1
37222 91 3-Cyclohexenyl 4-CH3 4 4
37407 92 c-C6H11CH2 H 5 5
37409 93 c-C6H11CH2 2-CH3 5 5
37410 94 c-C6H11CH2 3-CH3 5 5
37411 95 c-C6H11CH2 4-CH3 5 4
37412 96 c-C6H11CH2 2-C2H5 5 4
37422 97 c-C6H11(CH2)2 H 5 4
37424 98 c-C6H11(CH2)2 2-CH3 5 4
37425 99 c-C6H11(CH2)2 3-CH3 5 4
37426 100 c-C6H11(CH2)2 4-CH3 3 3
37427 101 c-C6H11(CH2)2 2-C2H5 4 1
37436 102 c-C6H11(CH2)3 H 5 4
37438 103 c-C6H11(CH2)3 2-CH3 1 2
37439 104 c-C6H11(CH2)3 3-CH3 2 2
37440 105 c-C6H11(CH2)3 4-CH3 1 2
37441 106 c-C6H11(CH2)3 2-C2H5 4 2
37453 107 C17H35 2-CH3 1 1
37454 108 C17H35 3-CH3 1 1
37455 109 C17H35 4-CH3 1 1
37456 110 C17H35 2-C2H5 1 1
37462 111 C12H25 2-CH3 1 1
37463 112 C12H25 3-CH3 1 1
37464 113 C12H25 4-CH3 1 1
37465 114 C12H25 2-C2H5 1 1
37470 115 C13H27 2-CH3 1 1
37471 116 C13H27 3-CH3 1 1
37472 117 C13H27 4-CH3 1 1
37473 118 C13H27 2-C2H5 1 1
37478 119 C15H31 2-CH3 1 1
37479 120 C15H31 3-CH3 1 1
37480 121 C15H31 4-CH3 1 1
37481 122 C15H31 2-C2H5 1 1
37489 123 C10H21 2-CH3 5 3
37490 124 C10H21 3-CH3 5 4
37492 125 C10H21 2-C2H5 1 1
37496 126 C11H23 3-CH3 1 1
37497 127 C11H23 4-CH3 1 1
37498 128 C11H23 2-C2H5 1 1
37771 129 C4H9O H 1 1
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ID Entry R R Experimental class Predicted class
37774 130 C6H13O H 1 1
37989 131 c-C6H11NH H 1 1
37992 132 C5H11O H 3 3
38140 133 c-C6H11CH2 H 4 5
38142 134 c-C5H9CH2 H 5 4
38423 135 c-C5H9(CH2)2 H 5 4
38739 136 1-Cyclohexenyl H 5 4
38816 137 2-Thiophenyl-CH2 H 4 2
38822 138 c-C6H10(1-CH3) H 5 4
38861 139 c-C5H9CH2 H 5 4
38871 140 2-Cyclopenten-1-yl-CH2 H 5 4
39008 141 c-C6H10(4-CH3) H 5 5
39012 142 c-C6H10(4-CH3) 2-CH3 5 4
39049 143 H2CCH(CH2)8 H 5 4
39177 144 c-C5H9(CH2)2 2-CH3 5 4
39178 145 c-C5H9(CH2)2 3-CH3 1 1
39179 146 c-C5H9(CH2)2 4-CH3 1 4
39180 147 c-C5H9(CH2)2 2-C2H5 1 3
39239 148 c-C5H9 H 3 4
39680 149 c-C3H5 H 4 3
39754 150 c-C3H5 2-CH3 2 2
39755 151 c-C3H5 4-CH3 2 2
39765 152 c-C3H5 2-C2H5 2 3
39775 153 c-C3H5 4-C6H5 1 1
39781 154 c-C5H9 2-CH3 3 4
39782 155 c-C5H9 3-CH3 3 4
39783 156 c-C5H9 4-CH3 3 4
39784 157 c-C5H9 2-C2H5 3 4
54017 158 c-C4H7 H 4 3
54422 159 CH3 3,3-(CH3)2 2 3
54456 160 2-Furanyl H 2 2
54458 161 2-Furanyl 2-CH3 4 4
54459 162 2-Furanyl 3-CH3 4 3
54460 163 2-Furanyl 4-CH3 4 2
54461 164 2-Furanyl 2-C2H5 4 3
54514 165 2-Thiophenyl H 1 2
54516 166 2-Thiophenyl 2-CH3 1 1
54917 167 2-Thiophenyl 3-CH3 1 2
54918 168 2-Thiophenyl 4-CH3 1 1
54919 169 2-Thiophenyl 2-C2H5 1 2
55059 170 2-CH3-3-furanyl 2-CH3 1 2
55070 171 2-CH3-3-furanyl 4-CH3 5 2
55127 172 3-Furanyl 2-CH3 1 2
55134 173 5-CH3-2-furanyl H 1 2
55166 174 3-CH3-C6H4 3-CH2OH 1 2
70312 175 5,5-Di-CH3-1,3,6-c-heptatrienyl H 1 1
70339 176 (CH3)2CCH(CH2)2(CH3)CCHCH2O(CH2)2 H 1 1
02746* 177 2-NO2-C6H4 H 1 1
02748* 178 4-NO2-C6H4 H 1 1
06539* 179 C4H9OOCCH2 H 2 4
06544* 180 c-C6H11OOCCH2 H 5 5
07695* 181 (C2H5)2NSO2 H 5 4
08183* 182 C12H25 H 1 4
11524* 183 NH2(CH2)2 H 2 1
11531* 184 C6H5(CH2)2 H 3 2
11580* 185 Piperidinyl-(CH2)6 H 1 5
11727* 186 Piperidinyl-(CH2)10 H 1 1
11737* 187 HO(CH2)2 H 1 1
15112* 188 C7H15 H 2 2
15117* 189 4-CH3-3-NO2-C6H3SO2 2-O 1 1
15234* 190 CNCH2 H 1 1
15238* 191 OHC H 3 1
30839* 192 4-CH3-C6H4SO2 H 1 2
32882 193 4-C2H5O-C6H4SO2 H 1 1
32884 194 4-CH3O-C6H4SO2 H 1 1
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ID Entry R R Experimental class Predicted class
34692 195 C2H5SO2 H 2 2
34693 196 C3H7SO2 H 2 2
34696 197 C5H11SO2 H 3 4
35719 198 ClCH2(CH2)2SO2 H 3 2
36253 199 C2H5SO2 2-C2H5 4 3
37916 200 C2H5OOCCH2 4-C2H5OOC 1 1
*Compounds used for validation.
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Table S2. Eleven N-acylpiperidines for which the repellent classes were previously measured
No.
Reagents Conditions Products Literature
2 R 3 R Solvent Time, h 4 Yield, % State/mp, °C ID State/mp, °C Ref.
1 2g CH2CH(CH2)8 3b H bTHF 5 4k 96 Oil 39049 Oil 1
2 2j 1-c-C6H9 3b H THF 24 4a 98 Oil 38739 Oil 2
3 2k c-C6H11 3b H THF 14.5 4b 97 Oil 36324 Oil 3
4 2k c-C6H11 3d 3-Me THF 24 4c 100 Oil 36537 Oil 4
5 2k c-C6H11 3e 4-Me THF 24 4d 99 Oil 36538 Oil 4
6 2l c-C5H9(CH2)2 3b H THF 24 4e 97 Oil 38423 Oil 5
7 2m 1-Me-c-C6H10 3d 3-Me THF 16.7 4f 71* Oil 39012 Novel
8 2k c-C6H11 3c 2-Et PhMe 8 4h 75* Oil 36539 Oil 4
9 2o c-C6H11CH2 3a 2-Me PhMe 24 4i 72* Oil 37409 Oil 4
10 2p c-C6H11(CH2)2 3a 2-Me PhMe 24 4j 94 Oil 37424 Oil 4
11 2p c-C6H11(CH2)2 3d 3-Me THF 17.5 4k 100 Oil 37425 Oil 4
*Purification by column chromatography.
1. House HO, Lee LF (1976) A new synthesis of 2-alkylpyrrolidines and 2-alkylpiperidines.
J Org Chem 41:863–869.
2. Oare DA, Henderson MA, Sanner MA, Heathcock CH (1990) Stereochemistry of the
Michael addition of N,N-disubstituted amide and thioamide enolates to  , -unsat-
urated ketones. J Org Chem 55:132–157.
3. Yoshifuji S, Arakawa Y, Nitta Y (1985) Ruthenium tetroxide oxidation of 1-azabicy-
cloalkan-2-ones. Chem Pharm Bull 33:5042–5047.
4. McGovern TP, Schreck CE, Jackson J, Beroza M (1975) n-Acylamides and n-
alkylsulfonamides from heterocyclic amines as repellents for yellow fever mosquitoes.
Mosq News 35(2):204–210.
5. Skau EL, Mod RR, Magne FC (1967) N-Acyl derivatives of cyclic imines as poly(vinyl
chloride) polymer plasticizer. US Patent 3,309,332.
6. Nambu H, Hata K, Matsugi M, Kita Y (2005) Efficient synthesis of thioesters and amides
from aldehydes by using an intermolecular radical reaction in water. Chem Eur J
11:719–727.
7. McGovern TP, Burden GS (1984) Cockroach repellents. US Patent 6,625,329; (1985)
Chem Abstr 102:144859.
8. McGovern TP, Schreck CE (1981) Alicyclic piperidine derivatives as insect repellents. US
Patent 4,291,041.
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Table S3. Twenty-three N-acylpiperidines as novel candidate repellents
No.
Reagents Conditions Products Literature
2 R 3 R Solvent Time, h 4
Yield,
% State/mp, °C State/mp, °C Ref.
1 2a Me 3a 2-Me THF 4 4a 71* Oil Oil 1
2 2b Et 3b H THF 4 4b 84 Oil Oil 2
3 2b Et 3c 2-Et THF 4 4c 75 Oil Oil 3
4 2c n-C6H13 3a 2-Me THF 72 4d 88 Oil Oil 4
5 2c n-C6H13 3d 3-Me THF 4 4e 76 Oil Oil 4
6 2d n-C7H15 3e 4-Me THF 5 4f 77 Oil Oil 4
7 2d n-C7H15 3f 4-Bn THF 4 4g 76 Oil Novel
8 2e n-C8H17 3c 2-Et THF 4 4h 83* Oil Oil 4
9 2f n-C9H19 3a 2-Me PhMe 24 4i 92 Oil Oil 5
10 2f n-C9H19 3e 4-Me THF 4 4j 83 Oil Oil 4
11 2 g CH2CH(CH2)8 3c 2-Et THF 72 4l 90* Oil Novel
12 2 g CH2CH(CH2)8 3f 4-Bn THF 4 4m 76 Oil Novel
13 2 g CH2CH(CH2)8 3e 4-Me THF 4 4n 95 Oil Novel
14 2 h n-C10H21 3b H THF 4 4o 92 Oil Oil 6
15 2i n-C11H23 3a 2-Me THF 4 4p 77 Oil Oil 7
16 2i n-C11H23 3d 3-Me THF 5 4q 92 Oil Oil 7
17 2n 4-Me-c-C6H10 3a 2-Me PhMe 24 4g 86*† Oil Oil 7
18 2p c-C6H11(CH2)2 3e 4-Me THF 24 4l 96 Oil Oil 8
19 2q c-C6H11(CH2)3 3e 4-Me THF 18.5 4m 100 Oil Oil 8
20 2l c-C5H9(CH2)2 3c 2-Et PhMe 24 4n 98 Oil Novel
21 2p c-C6H11(CH2)2 3c 2-Et PhMe 24 4o 93* Oil Oil 8
22 2o c-C6H11CH2 3f 4-Bn THF 18 4p 100 50–52 Novel
23 2p c-C6H11(CH2)2 3f 4-Bn THF 24 4q 99 Oil Novel
*Purification by column chromatography.
†Mixture of cis and trans (1:1).
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Table S4. Calculated free energies of activation at coalescence
Comp. Rotamers* Protons , ppm , Hz Tc, °C k, s1 G‡, kcalmol1
4p a H-2eq 4.58 375 80 832.5 16.1
4p b H-2eq 3.33
4p a CH3 0.67 15 30 33.3 16.1
4p b CH3 0.62
4q a H-2eq 4.58 375 80 832.5 16.1
4q b H-6eq 3.33
4q a CH3 0.68 15 30 33.3 16.1
4q b CH3 0.63
4c a H-2eq 4.57 252 77 559.4 16.2
4c b H-2eq 3.73
4c a H-6eq 4.43 264 77 586.1 16.2
4c b H-6eq 3.55
4c a H-6ax 2.97 150 65 333 16.5
4c b H-6ax 2.47
4c a CH2CH3 0.81 15 37 33.3 16.0
4c b CH2CH3 0.76
*Assignments a and b are nominal.
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Table S5. Intercorrelation matrix
Descriptor No. 1 2 3 4 5 6 7 8
WPSA-2 weighted PPSA (PPSA2*TMSA/1000) 1 1
Maximum 1-electron reactivity index for atom C 2 0.08 1.00
Maximum e–e repulsion for bond C–C 3 0.14 0.01 1.00
Principal moment of inertia C 4 0.63 0.03 0.00 1.00
YZ shadow/YZ rectangle 5 0.08 0.03 0.00 0.16 1.00
Molecular volume/XYZ box 6 0.50 0.13 0.05 0.53 0.41 1.00
RNCG relative negative charge
(QMNEG/QTMINUS)
7 0.78 0.08 0.02 0.92 0.10 0.52 1.00
Minimum e–n attraction for bond C–O 8 0.00 0.05 0.03 0.09 0.28 0.16 0.04 1.00
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Table S6. Predicted and observed PT values and the most active compounds selected
ID
25 mol/liter 2.5 mol/liter
Experimental Predicted Difference Experimental Predicted Difference
4a* 2.00 1.50 3.50 2.00 2.40 0.40
4b* 5.00 1.40 6.40 4.00 5.06 1.06
4c 5.00 8.36 3.36 3.00 4.26 1.26
4d 17.00 32.43 15.43 5.00 4.30 0.70
4e 15.50 38.34 22.84 7.50 6.90 0.60
4f 48.00 40.84 7.16 8.00 7.31 0.69
4g 13.00 10.79 2.21 7.00 6.72 0.28
4h 43.00 37.59 5.41 9.50 9.66 0.16
4i 49.50 36.83 12.67 8.00 7.60 0.40
4j 41.00 32.07 8.93 11.50 9.19 2.31
4k 50.00 60.63 10.63 13.50 11.08 2.42
4l 53.00 55.96 2.96 9.00 10.26 1.26
4m 8.50 8.99 0.49 8.00 6.74 1.26
4n 73.00 59.08 13.92 10.50 8.84 1.66
4o 39.50 31.59 7.91 13.00 11.27 1.73
4p 14.50 31.45 16.95 5.00 8.24 3.24
4q 19.50 25.73 6.23 5.50 10.95 5.45
4a 17.00 23.19 6.19 5.00 5.04 0.04
4b 14.00 18.12 4.12 8.00 8.30 0.30
4c 17.00 25.83 8.83 6.00 5.47 0.53
4d 24.50 27.29 2.79 8.50 8.60 0.10
4e 35.00 27.74 7.26 9.00 6.03 2.97
4f 12.00 24.86 12.86 7.00 7.76 0.76
4g 33.00 24.79 8.21 8.50 9.33 0.83
4h 21.50 22.45 0.95 7.00 7.30 0.30
4i 29.50 32.58 3.08 7.50 7.66 0.16
4j 47.50 33.00 14.50 10.00 11.16 1.16
4k 35.00 36.16 1.16 9.00 6.79 2.21
4l 45.50 36.25 9.25 8.00 6.98 1.02
4m 33.00 35.97 2.97 3.00 5.54 2.54
4n 40.50 28.00 12.50 8.50 6.42 2.08
4o 42.00 38.56 3.44 10.50 10.41 0.09
4p 3.00 4.26 1.26 1.50 2.88 1.38
4q 12.00 12.17 0.17 1.00 1.53 0.53
*Predicted as having negative PT at 25 mol/cm2.
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